<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Indevus, Maker of ‘Male Menopause’ Drug, Agrees to $370M Takeover by Endo</title>
	<atom:link href="http://www.xconomy.com/boston/2009/01/05/indevus-maker-of-male-menopause-drug-agrees-to-370m-takeover-by-endo-pharmaceuticals/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/boston/2009/01/05/indevus-maker-of-male-menopause-drug-agrees-to-370m-takeover-by-endo-pharmaceuticals/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sat, 11 Feb 2012 03:54:18 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
	<item>
		<title>By: James Menozac</title>
		<link>http://www.xconomy.com/boston/2009/01/05/indevus-maker-of-male-menopause-drug-agrees-to-370m-takeover-by-endo-pharmaceuticals/comment-page-1/#comment-239566</link>
		<dc:creator>James Menozac</dc:creator>
		<pubDate>Sun, 24 Oct 2010 19:00:03 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=7457#comment-239566</guid>
		<description>In this tough and difficult economic times organisations like Indevus Pharmaceuticals need to rethink their financial strategies to keep afloat.

No doubt the slapped down by an FDA has triggered this development.</description>
		<content:encoded><![CDATA[<p>In this tough and difficult economic times organisations like Indevus Pharmaceuticals need to rethink their financial strategies to keep afloat.</p>
<p>No doubt the slapped down by an FDA has triggered this development.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Headlines for Jan 5-11 &#124; Health Content Advisors</title>
		<link>http://www.xconomy.com/boston/2009/01/05/indevus-maker-of-male-menopause-drug-agrees-to-370m-takeover-by-endo-pharmaceuticals/comment-page-1/#comment-44459</link>
		<dc:creator>Headlines for Jan 5-11 &#124; Health Content Advisors</dc:creator>
		<pubDate>Wed, 14 Jan 2009 19:04:03 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=7457#comment-44459</guid>
		<description>[...] » Indevus, Maker of ‘Male Menopause’ Drug, Agrees to $370M Takeover by Endo &#124; Xconomy [...]</description>
		<content:encoded><![CDATA[<p>[...] » Indevus, Maker of ‘Male Menopause’ Drug, Agrees to $370M Takeover by Endo | Xconomy [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Early Menopause Symptom &#187; Blog Archive &#187; Know symptom menopause</title>
		<link>http://www.xconomy.com/boston/2009/01/05/indevus-maker-of-male-menopause-drug-agrees-to-370m-takeover-by-endo-pharmaceuticals/comment-page-1/#comment-44172</link>
		<dc:creator>Early Menopause Symptom &#187; Blog Archive &#187; Know symptom menopause</dc:creator>
		<pubDate>Thu, 08 Jan 2009 12:25:46 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=7457#comment-44172</guid>
		<description>[...] Indevus Pharmaceuticals has reached the end of its road. The Lexington, MA-based biotech company (NASDAQ: [[ticker:IDEV]]) said today it has agreed to be. Early Menopause Symptoms&#8230; [...]</description>
		<content:encoded><![CDATA[<p>[...] Indevus Pharmaceuticals has reached the end of its road. The Lexington, MA-based biotech company (NASDAQ: [[ticker:IDEV]]) said today it has agreed to be. Early Menopause Symptoms… [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

